Rare diseases
Investigational molecules
Locations
131 Oyster Point Boulevard, 94080-2029, United States
The sponsor focuses extensively on developing therapeutic interventions for progressive neurodegenerative disorders, with particular emphasis on conditions affecting cognitive function and motor control. Research efforts concentrate on addressing the underlying biological mechanisms that drive neuronal degeneration and impair quality of life in affected individuals.
Investigations target both early and advanced stages of these conditions, exploring novel approaches to modify disease progression and preserve neurological function.
Alector LLC runs clinical trials in conditions such as Neurodegenerative disorder, Dementia Alzheimer's type, Frontotemporal dementia, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
Belgium
FranceBelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
